PRAQuestionFieldsforQSub

Q-Submission and Early Payor Feedback Request Programs for Medical Devices

PRAQuestionFieldsforQSub

OMB: 0910-0756

Document [docx]
Download: docx | pdf

PRA Question Fields for Q-Sub SMART


Withdrawal

  • Reason for withdrawal? (Compiling the Administrative File for Premarket Submission Decisions SOP)


Accessory Classification Eligibility Review (“Medical Device Accessories – Describing Accessories and Classification Pathways” Guidance Document)

  • Was request included in PMA or 510(k) of parent device?

  • Has accessory been previously classified?

  • Is applicant a manufacturer/importer of device via PMA, 510(k), or De Novo?

  • Is article a finished device?

  • Is device intended to be used with one or more parent device(s)?

  • Does device support/supplement/augment performance of parent device?


Breakthrough Designation (§ 515B of the Food, Drug, and Cosmetic Act, and “Breakthrough Devices Program” Guidance Document)

  • Is device subject to PMA/De Novo/510(k)?

  • Will device provide for more effective treatment or diagnosis of life threatening or irreversibly debilitating human disease or conditions?

  • Does device meet one of these criterion: breakthrough technology, no approved/cleared alternative, offers significant advantages over existing alternatives, or availability is in the best interest of patients?

  • Was patient perspective information considered in determining whether the designation criteria were met?


STeP Eligibility (“Safer Technologies Program for Medical Devices” Guidance Document)

  • Is device subject to PMA/De Novo/510(k)?

  • Is device ineligible for Breakthrough?

  • Is device expected to meet at least one of the following safety innovations: reduce occurrence of serious adverse event, reduce occurrence of device failure mode, reduce occurrence of use-related hazard or use error, improve safety of another device or intervention?

  • Is product a device-led combination product?


Submission Characteristics

  • Will future marketing pathway likely be PMA, De Novo, HDE, or Expedited 510(k)? (Not requested of sponsor, reviewer only)

  • How many consults from outside Center? (Not requested of sponsor, reviewer only)

  • How many questions posed by applicant? (Not requested of sponsor, reviewer only)

  • Will feedback be sent to applicant which goes beyond questions asked? (Not requested of sponsor, reviewer only)

  • Did applicant submit a DDP? (Not requested of sponsor, reviewer only)

  • Did applicant request feedback that will be reviewed as future supplement? (Not requested of sponsor, reviewer only)

  • Is applicant OUS? (Not requested of sponsor, reviewer only)

  • Is device a combination product? (“Requests for Feedback and Meetings for Medical Device Submissions: The Q-submission Program” Guidance Document)

  • What type of expedited programs interaction is requested? (Not requested of sponsor, reviewer only)

  • Was agreement on DDP reached? (Not requested of sponsor, reviewer only)

  • Will tracked changes version of DDP be provided via email? (Not requested of sponsor, reviewer only)

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Modified0000-00-00
File Created2023-08-28

© 2024 OMB.report | Privacy Policy